3,905 Shares in Masimo Co. (NASDAQ:MASI) Purchased by RFG Advisory LLC

RFG Advisory LLC acquired a new position in shares of Masimo Co. (NASDAQ:MASI) during the fourth quarter, HoldingsChannel reports. The fund acquired 3,905 shares of the medical equipment provider’s stock, valued at approximately $645,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. UMB Bank n.a. grew its stake in shares of Masimo by 180.9% during the fourth quarter. UMB Bank n.a. now owns 191 shares of the medical equipment provider’s stock valued at $32,000 after purchasing an additional 123 shares during the last quarter. Trust Co. of Vermont acquired a new position in Masimo during the 4th quarter worth $33,000. NBC Securities Inc. boosted its position in Masimo by 47.1% in the 3rd quarter. NBC Securities Inc. now owns 228 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 73 shares during the last quarter. Northwestern Mutual Wealth Management Co. increased its stake in shares of Masimo by 133.3% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 350 shares of the medical equipment provider’s stock valued at $44,000 after buying an additional 200 shares during the period. Finally, GAMMA Investing LLC raised its position in shares of Masimo by 136.5% during the fourth quarter. GAMMA Investing LLC now owns 466 shares of the medical equipment provider’s stock worth $77,000 after acquiring an additional 269 shares during the last quarter. Institutional investors and hedge funds own 85.96% of the company’s stock.

Masimo Price Performance

Shares of MASI stock opened at $170.24 on Monday. The company has a quick ratio of 1.11, a current ratio of 2.01 and a debt-to-equity ratio of 0.50. Masimo Co. has a 12-month low of $101.61 and a 12-month high of $180.97. The firm has a fifty day moving average of $170.32 and a 200-day moving average of $142.65. The firm has a market capitalization of $9.11 billion, a price-to-earnings ratio of 117.41 and a beta of 1.01.

Masimo (NASDAQ:MASI) last posted its earnings results on Tuesday, November 5th. The medical equipment provider reported $0.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.84 by $0.14. The firm had revenue of $504.60 million during the quarter, compared to analysts’ expectations of $502.87 million. Masimo had a return on equity of 14.98% and a net margin of 3.85%. The company’s revenue was up 5.4% on a year-over-year basis. During the same period in the previous year, the firm earned $0.63 earnings per share. On average, equities research analysts forecast that Masimo Co. will post 4.1 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts recently issued reports on MASI shares. Raymond James raised their price target on Masimo from $170.00 to $194.00 and gave the company an “outperform” rating in a report on Friday, December 27th. Stifel Nicolaus restated a “buy” rating and issued a $190.00 price objective (up from $170.00) on shares of Masimo in a report on Friday, November 22nd. BTIG Research lifted their target price on shares of Masimo from $166.00 to $170.00 and gave the stock a “buy” rating in a report on Monday, October 14th. Piper Sandler increased their price target on Masimo from $180.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday, December 18th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Masimo in a research note on Wednesday, January 22nd. Three analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, Masimo has a consensus rating of “Moderate Buy” and an average target price of $179.67.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.